Systemic effects of severe trauma on the function and apoptosis of human skeletal cells

Journal of Bone and Joint Surgery - Series B

Volumn 88, Issue 10, 2006, Pages 1394-1400

  Eid, K ^a   Labler, L ^a   Ertel, W ^b   Trentz, O ^a   Keel, M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE;

ADULT; APOPTOSIS; ARTICLE; BLOOD ANALYSIS; BONE CELL; BONE DEVELOPMENT; BONE INJURY; BONE MARROW CELL; BONE MATRIX; CELL ACTIVITY; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MALE; OSTEOBLAST; PRIORITY JOURNAL; STROMA CELL;

ADULT; ALKALINE PHOSPHATASE; APOPTOSIS; BONE MARROW; CELL DIVISION; CELLS, CULTURED; CONNECTIVE TISSUE CELLS; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; GENE EXPRESSION; HUMANS; INJURY SEVERITY SCORE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; OSTEOBLASTS; OSTEOGENESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS; WOUNDS AND INJURIES;

EID: 33750380176     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.88B10.17139     Document Type: Article

References (44)

1. Sawyer JR, Myers MA, Rosier RN, Puzas JE. Heterotopic ossification: clinical and cellular aspects. Calcif Tissue Int 1991;49:208-15.
2. Garland DE. A clinical perspective on common forms of acquired heterotopic ossification. Clin Orthop 1991;263:13-29.
3. Wharton GW, Morgan TH. Ankylosis in the paralyzed patient. J Bone Joint Surg [Am] 1970;52-A:105-12.
4. Keel M, Ertel W, Trentz O. Bilateral hip ankylosis caused by heterotopic ossification after isolated severe craniocerebral trauma. Unfallchirurg 2000;103:243-7 (in German).
5. Garland DE, Blum CE, Waters RL. Periarticular heterotopic ossification in head-injured adults: incidence and location. J Bone Joint Surg [Am] 1980;62-A:1143-6.
6. Garland DE, O'Halloren RM. Fractures and dislocations about the elbow in the head-injured adult. Clin Orthop 1982;168:38-41.
7. Spencer RF. The effect of head injury on fracture healing: a quantitative assessment. J Bone Joint Surg [Br] 1987;69-B:525-8.
8. Kushwaha VP, Garland DG. Extremity fractures in the patient with a traumatic brain injury. J Am Acad Orthop Surg 1998;6:298-307.
9. Garland DE, Alday B, Venos KG. Heterotopic ossification and HLA antigens. Arch Phys Med Rehabil 1984;65:531-2.
10. Larson JM, Michalski JP, Collacott EA, et al. Increased prevalence of HLA-B27 in patients with ectopic ossification following traumatic spinal cord injury. Rheumatol Rehabil 1981;20:193-7.
11. Shafritz AB, Shore EM, Gannon FH, et al. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 1996:335:555-61.
12. Clements NC Jr, Camilli AE. Heterotopic ossification complicating critical illness. Chest 1993;104:1526-8.
13. Chalmers J, Gray DH, Rush J. Observations on the induction of bone in soft tissues. J Bone Joint Surg [Br] 1975;57-B:36-45.
14. Bidner SM, Rubins IM, Desjardins JV, Zukor DJ, Goltzman D. Evidence for a humoral mechanism for enhanced osteogenesis after head injury. J Bone Joint Surg [Am] 1990;72-A:1144-9.
15. Wildburger R, Zarkovic N, Ieb G, at al. Post-traumatic changes in insulin-like growth factor type 1 and growth hormone in patients with bone fractures and traumatic brain injury. Wien Klin Wochenschr 2001;113:119-26.
16. Wildburger R, Zarkovic N, Tonkovic G, et al. Post-traumatic hormonal disturbances: prolactin as a link between head injury and enhanced osteogenesis. J Endocrinol Invest 1998;21:78-86.
17. Klein BY, Shohami E, Reikhinshtein Y, Ben-Bassat H, Liebergall M. Serum-mediated osteogenic effects of head injury on cultured rat marrow stromal cells. Calcif Tissue Int 1999;65:217-22.
18. Kurer MH, Khoker MA, Dandona P. Human osteoblast stimulation by sera from paraplegic patients with heterotopic ossification. Paraplegia 1992;30:165-8.
19. Wildburger R, Zarkovic N, Egger G, et al. Comparison of the values of basic fibroblast growth factor determined by an immunoassay in the sera of patients with traumatic brain injury and enhanced osteogenesis and the effects of the same sera on the fibroblast growth in vitro. Eur J Clin Chem Clin Biochem 1995;33:693-8.
20. Collicott PE, Hughes I. Training in advanced trauma life support. JAMA 1980;243: 1156-9.
21. Greenspan J, McLellan B, Greig H. Abbreviated injury scale and injury severity score: a scoring chart. J Trauma 1985;25:60-4.
22. Trentz O. Polytrauma: pathophysiology, priorities, and management. In: Rüedi TP, Murphy WW eds. AO principles of fracture management. New York: Thieme-Verlag, 2000:661-73.
23. No authors listed. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
25. Mizuno S, Glowacki J. Chondroinduction of human dermal fibroblasts by demineralized bone in three-dimensional culture. Exp Cell Res 1996;227:89-97.
26. Mueller SM, Mizuno S, Gerstenfeld LC, Glowacki J. Medium perfusion enhances osteogenesis by murine osteosarcoma cells in three-dimensional collagen sponges. J Bone Miner Res 1999;14:2118-26.
27. Bills CE, Eisenberg H, Pallante SL. Complexes of organic acids with calcium phosphate: the von Kossa stain as a clue to the composition of bone mineral. John Hopkins Med J 1971;128:194-207.
28. Robbins JR, Goldring MR. Tissue engineering. In: Morgan JR, Yarmush ML eds. Methods in molecular medicine. Totowa: Humana Press, 1997:173-98.
29. Gronthos S, Zannettino AC, Graves SE, et al. Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J Bone Miner Res 1999:14:47-56.
30. O'Connor JP. Animal models of heterotopic ossification. Clin Orthop 1998;346:71-80.
31. Mueller SM, Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 2001;82:583-90.
32. Marie PJ, Debiais F, Hay E. Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling. Histol Histopathol 2002;17:877-85.
33. Tumber A, Meikle MC, Hill PA. Autocrine signals promote osteoblast survival in culture. J Endocrinol 2000;167:383-90.
34. Chaudhary LR, Hruska KA. The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells. J Cell Biochem 2001;81:304-11.
35. Mansukhani A, Bellosta P, Sahni M, Basilico C. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol 2000:149: 1297-308.
36. Mogi M, Kondo A, Kinpara K, Togari A. Anti-apoptotic action of nerve growth factor in mouse osteolblastic cell line. Life Sci 2000;67:1197-206.
37. Kossmann T, Stahel PF, Lenzlinger PM, et al. Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab 1997;17:280-9.
38. Ertel W, Keel M, Buergi U, et al. Granulocyte colony-stimulating factor inhibits neutrophil apoptosis at the local site after severe head and thoracic injury. J Trauma 1999;46:784-92.
39. Ertel W, Keel M, Infanger M, et al. Circulating mediators in serum of injured patients with septic complications inhibit neutrophil apoptosis through up-regulation of protein-tyrosine phosphorylation. J Trauma 1998;44:767-75.
40. Keel M, Ungethum U, Steckholzer U, et al. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 1997;90:3356-63.
41. Brach MA, deVos S, Gruss HJ, Herrmann F. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 1992;80:2920-4.
42. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992;80:2012-20.
43. Lee A, Whyte MK, Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 1993;54:283-8.
44. Beeton CA, Chatfield D, Brooks RA, Rushton N. Circulating levels of interleukin-6 and its soluble receptor in patients with head injury and fracture. J Bone Joint Surg [Br] 2004;86-B:912-17.